Segment and Geographic Information - Reconciliation of Reportable Segment Operating Income (Loss) to Corresponding Consolidated Amounts (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Total revenue	$ 178,366	$ 139,652
Amortization of other intangible assets	11,500	8,000
Purchase accounting impact on inventory	2,869
Operating income (loss)	(27,685)	(325)
Interest income	10,708	35
Interest expense	(43)	(455)
Other income (expense)	1,145	(1,077)
Loss before income taxes	(15,875)	(1,822)
Completed Technology
Segment Reporting Information [Line Items]
Amortization of other intangible assets	4,168	1,773
Acquired Intangible Assets
Segment Reporting Information [Line Items]
Amortization of other intangible assets	7,372	6,272
Life Sciences Products
Segment Reporting Information [Line Items]
Total revenue	89,661	49,877
Operating income (loss)	(3,798)	4,388
Life Sciences Services
Segment Reporting Information [Line Items]
Total revenue	88,706	89,775
Operating income (loss)	(4,612)	7,883
Operating Segments
Segment Reporting Information [Line Items]
Total revenue	178,366	139,652
Segment Reconciling Items
Segment Reporting Information [Line Items]
Operating income (loss)	(8,410)	12,271
Corporate, Non-Segment
Segment Reporting Information [Line Items]
Other unallocated corporate expense (income)	$ 3,405	$ 4,378